1. Home
  2. FNUC vs LUNG Comparison

FNUC vs LUNG Comparison

Compare FNUC & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FNUC

Frontier Nuclear and Minerals Inc. Common Shares

N/A

Current Price

$1.92

Market Cap

62.6M

ML Signal

N/A

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$1.37

Market Cap

57.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNUC
LUNG
Founded
2018
1995
Country
Canada
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Industrial Specialties
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.6M
57.9M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
FNUC
LUNG
Price
$1.92
$1.37
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$5.38
AVG Volume (30 Days)
586.4K
330.3K
Earning Date
06-24-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.64
EPS
N/A
N/A
Revenue
N/A
$90,497,000.00
Revenue This Year
N/A
$2.48
Revenue Next Year
N/A
$18.46
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.01
52 Week Low
$1.76
$1.13
52 Week High
$2.82
$3.88

Technical Indicators

Market Signals
Indicator
FNUC
LUNG
Relative Strength Index (RSI) 42.10 47.35
Support Level $1.92 $1.36
Resistance Level $2.52 $1.45
Average True Range (ATR) 0.24 0.11
MACD -0.04 -0.02
Stochastic Oscillator 22.35 23.29

Price Performance

Historical Comparison
FNUC
LUNG

About FNUC Frontier Nuclear and Minerals Inc. Common Shares

Frontier Nuclear and Minerals Inc is developing a U.S.-focused front-end nuclear fuel cycle company through a portfolio of U.S. uranium exploration and development projects in Wyoming, Colorado, and Utah, together with investments in next-generation uranium enrichment and small modular reactors. Frontier Nuclear is actively evaluating value-accretive investment opportunities in other sectors of the domestic U.S. nuclear fuel cycle. The group is developing a portfolio of critical minerals projects in America, Canada, and Namibia, including uranium, tantalum, cesium, and lithium. Its projects are Engo Valley, Pine Ridge, Shatford Lake, Snow Lake Lithium, and Tallahassee.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.

Share on Social Networks: